BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 9.02.2005

International Conference on Harmonisation; Draft Guidance on Q8 Pharmaceutical Development; Availability

The Food and Drug Administration (FDA) is announcing the availability of a draft guidance entitled "Q8 Pharmaceutical Development." The draft guidance was prepared under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). This draft guidance describes the suggested contents for the pharmaceutical development section in the quality module of a regulatory submission in the ICH M4 Common Technical Document (CTD) format. The draft guidance is intended to assist in the development of pharmaceutical studies that provide scientific understanding to support the establishment of specifications and manufacturing controls and serve as the basis for evaluating risk management over the life cycle of the product.

Source: Federal Register — Food and Drug AdministrationOpen original release →